Shinji Ueno

Hirosaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Electronegative ERG revealing melanoma-associated retinopathy in a patient with trametinib-associated retinopathy.

Electronegative ERG revealing melanoma-associated retinopathy in a patient with trametinib-associated retinopathy.

Journal: Documenta ophthalmologica. Advances in ophthalmology

Published: June 02, 2026

Initial Site of Macular Involvement in Central Retinal Dystrophies Revealed by Fundus Autofluorescence and Optical Coherence Tomography.

Initial Site of Macular Involvement in Central Retinal Dystrophies Revealed by Fundus Autofluorescence and Optical Coherence Tomography.

Journal: Investigative ophthalmology & visual science

Published: May 19, 2026

Diagnostic Value of Intra-orbital Oculomotor Nerve Short Tau Inversion Recovery Hyperintensity in Oculomotor Nerve Palsy.

Diagnostic Value of Intra-orbital Oculomotor Nerve Short Tau Inversion Recovery Hyperintensity in Oculomotor Nerve Palsy.

Journal: AJNR. American journal of neuroradiology

Published: April 02, 2026

A study to learn how well the combination of encorafenib and binimetinib works and how safe it is in adults with thyroid cancer: a plain language summary.

A study to learn how well the combination of encorafenib and binimetinib works and how safe it is in adults with thyroid cancer: a plain language summary.

Journal: Future oncology (London, England)

Published: March 24, 2026

Preliminary Experience with New Dual-Mobility System for Small Japanese Patients.

Preliminary Experience with New Dual-Mobility System for Small Japanese Patients.

Journal: Journal of clinical medicine

Published: March 13, 2026

Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

Journal: International journal of clinical oncology

Published: March 12, 2026

DELETION INVOLVING EXON 18 OF RPGRIP1 IS a MAJOR CAUSE OF ACHROMATOPSIA.

DELETION INVOLVING EXON 18 OF RPGRIP1 IS a MAJOR CAUSE OF ACHROMATOPSIA.

Journal: Retina (Philadelphia, Pa.)

Published: February 10, 2026

Genotype-Phenotype Correlations in RPGRIP1-Associated Retinal Dystrophy in a Nationwide Japanese Cohort.

Genotype-Phenotype Correlations in RPGRIP1-Associated Retinal Dystrophy in a Nationwide Japanese Cohort.

Journal: American journal of ophthalmology

Published: January 29, 2026

Longitudinal change in anterior chamber depth and its determinants: a median 4.9-year follow-up of 2,247 Japanese adults.

Longitudinal change in anterior chamber depth and its determinants: a median 4.9-year follow-up of 2,247 Japanese adults.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: November 16, 2025

Comparative plastid genomics of Hippophae reveals phylogenetic relationships and provides candidate DNA markers for taxonomic identification.

Comparative plastid genomics of Hippophae reveals phylogenetic relationships and provides candidate DNA markers for taxonomic identification.

Journal: Scientific reports

Published: October 31, 2025

Longitudinal evaluation of peripheral photoreceptor atrophy in fundus albipunctatus.

Longitudinal evaluation of peripheral photoreceptor atrophy in fundus albipunctatus.

Journal: Japanese journal of ophthalmology

Published: October 06, 2025

Risk Factors for Adult Axial Length Elongation: A 5-Year Population-Based Cohort Study.

Risk Factors for Adult Axial Length Elongation: A 5-Year Population-Based Cohort Study.

Journal: Ophthalmology science

Published: October 04, 2025

Showing 1-12 of 158

Last Updated: 09/26/2026